Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer and Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05904730
What this trial is testing

Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations

Who this might be right for
Breast CancerOvarian CancerBreast Neoplasms+5 more
Lynkcell Europe 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06334432
What this trial is testing

Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorHER2-negative Breast CancerMetastatic Castration-resistant Prostate Cancer (mCRPC)+2 more
Nuvation Bio Inc. 466
Testing effectiveness (Phase 2)Looking for participantsNCT00722228
What this trial is testing

Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

Who this might be right for
Colorectal CancerOvarian CancerGastric Cancer+4 more
Hadassah Medical Organization 50
Testing effectiveness (Phase 2)Study completedNCT00039793
What this trial is testing

Massage Therapy for Cancer-Related Fatigue

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+1 more
National Center for Complementary and Integrative Health (NCCIH) 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04152499
What this trial is testing

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

Who this might be right for
Epithelial Ovarian CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+7 more
Klus Pharma Inc. 1,410
Not applicableStudy completedNCT00578006
What this trial is testing

Internet-based System for Cancer Patients to Self-report Toxicity

Who this might be right for
Cervical CancerLung CancerProstate Cancer+4 more
Memorial Sloan Kettering Cancer Center 1,007
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Not applicableUnknownNCT02303353
What this trial is testing

Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy

Who this might be right for
Carcinoma
SPGO Research Mannheim GmbH 2,000
Testing effectiveness (Phase 2)UnknownNCT04398446
What this trial is testing

Effect of Hemp-CBD on Patients With CIPN

Who this might be right for
Chemotherapy-induced Peripheral NeuropathyColorectal Cancer Stage IIColorectal Cancer Stage III+4 more
Main Line Health 56
Not applicableLooking for participantsNCT05007834
What this trial is testing

Metabolism, Circadian Rhythms and Ovarian Function

Who this might be right for
Chemotherapy-Induced Amenorrhea
University Hospital, Lille 50
Early research (Phase 1)Active Not RecruitingNCT06238479
What this trial is testing

LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 490
Early research (Phase 1)Active Not RecruitingNCT05277051
What this trial is testing

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 152
Not applicableNot Yet RecruitingNCT07236359
What this trial is testing

Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant Reconstruction

Who this might be right for
Breast ReconstructionBreast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)+1 more
Beaumont Hospital 108
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Not applicableStudy completedNCT02585362
What this trial is testing

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program

Who this might be right for
Lung CancerGastro-Intestinal CancerBreast Cancer+5 more
Kantonsspital Winterthur KSW 52
Early research (Phase 1)Study completedNCT01234012
What this trial is testing

Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1

Who this might be right for
Solid Tumor
ImmunoFrontier, Inc. 23
Not applicableLooking for participantsNCT05297734
What this trial is testing

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Who this might be right for
End of LifeCancer
Stanford University 2,996
Next Page